Astria Therapeutics (ATXS) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.86
-0.69
-0.51
-0.34

Details

Expected EPS
-0.34
Actual EPS
-0.38
Surprise EPS
-0.04
Surprise Percent
+11.76%

Description

Astria Therapeutics (ATXS) has reported earnings of -0.38 per share for Q2 2024.

0 Comments

Share your thoughts